Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.885 USD | -2.58% | +11.42% | +170.43% |
15/05 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
15/05 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+170.43% | 105.58Cr | |
+8.85% | 11TCr | |
+11.47% | 10TCr | |
-12.64% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-3.08% | 1.79TCr | |
+7.80% | 1.43TCr | |
+35.67% | 1.25TCr |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Transcript : Arcutis Biotherapeutics, Inc. - Special Call